Stocktoria
MEDIFAST INC MED
NYSE · XNYS · stock · Miscellaneous Food Preparations & Kindred Products · website · IPO 1993-12-30
MEDIFAST INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $385.8M | $602.5M | $1.1B | $1.6B | $1.5B |
| Gross profit | $275.2M | $444.6M | $775.9M | $1.1B | $1.1B |
| R&D expense | $4.3M | $4.6M | $4.6M | $4.5M | $4.4M |
| SG&A expense | $289.4M | $441.7M | $649.4M | $955.6M | $911.4M |
| Operating income | -$14.2M | $2.9M | $126.4M | $184.8M | $216.2M |
| Income tax | $13.0M | $1.7M | $29.4M | $40.5M | $52.1M |
| Net income | -$18.7M | $2.1M | $99.4M | $143.6M | $164.0M |
| EPS (diluted) | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 |
| Operating cash flow | $6.9M | $24.5M | $147.7M | $194.6M | $94.5M |
| Free cash flow | $1.2M | $17.0M | $141.2M | $177.9M | $60.3M |
| Cash & equivalents | $89.3M | $90.9M | $94.4M | $87.7M | $104.2M |
| Inventory | $20.2M | $42.4M | $54.6M | $118.9M | $180.0M |
| Total assets | $248.0M | $284.2M | $309.9M | $316.2M | $398.3M |
| Total liabilities | $49.1M | $74.1M | $108.4M | $161.2M | $195.9M |
| Shareholders' equity | $198.9M | $210.1M | $201.5M | $155.0M | $202.5M |
Source: SEC EDGAR filings · CIK 0000910329 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.